Earnings call Cooper Companies reported Q4 revenue of $1.065B (+4.6% YoY, +3.4% organic) and non-GAAP EPS of $1.15 (+11% YoY), marking its eighth straight earnings beat. FY26 guidance implies 4.5%-5.5 ...

Cooper Companies reported its Q4 2025 earnings, surpassing Wall Street expectations with an EPS of $1.15 against a forecast of $1.11. The company also reported revenues of $1.065 billion, slightly ...

Please provide your email address to receive an email when new articles are posted on . Experts advise not waiting until children progress to start myopia control. Options include atropine, ...

Cooper Companies (NASDAQ:COO) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of ...

Wondering what to buy at The Woodleigh Mall? Topping our list is OJO Visioncare, an optometry and optical practice in Singapore that focuses on both eye and hearing health. Floral Train is a ...

The Acuvue Oasys Max 1-Day Multifocal marks the first and only daily disposable contact lens to be available for people with both astigmatism and presbyopia. First and only daily disposable lens for ...

Thank you for standing by. At this time, we would like to welcome you to the Q2 2025 Cooper Companies Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

Earnings call Cooper Companies reported Q2 FY25 revenue of $1.002B, up 7% organically, with non-GAAP EPS of $0.96, up 14% YoY. Despite strong execution, the company lowered its full-year organic ...

Moving to frequent replacement lenses, Biofinity continues to deliver great results led by the strong performance of our Toric multifocals and industry-leading extended range offerings. Biofinity ...

Ladies and gentlemen, thank you for standing by. My name is [indiscernible], and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2025 Cooper ...